755 (Temozolomide 180 mg)
Pill with imprint 755 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 755
Temozolomide
- Imprint:
- 755
- Strength:
- 180 mg
- Color:
- Orange & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Alkylating agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer:
- Cadila Healthcare Limited
- National Drug Code (NDC):
- 68382-0755
More about temozolomide
- Temozolomide Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: alkylating agents
Consumer resources
- Temozolomide
- Temozolomide Capsules
- Temozolomide Injection
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
Other brands: Temodar
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
